Messenger Rna (mrna) Vaccines - Vaccines

Relevant Publications

Supercoiled DNA percentage: A key in-process control of linear DNA template for mRNA drug substance manufacturing.

Issue Release: 2024

Silk-gelatin hybrid hydrogel: a potential carrier for RNA therapeutics.

Issue Release: 2024

COVID-19 Vaccine-Associated Uveitis in Patients With a History of Uveitis.

Issue Release: 2024

Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers.

Issue Release: 2024

COVID-19 vaccination among adolescents and young adults with chronic kidney conditions: a single-center experience.

Issue Release: 2024

A lipid nanoparticle platform incorporating trehalose glycolipid for exceptional mRNA vaccine safety.

Issue Release: 2024

Development of Glycan-masked SARS-CoV-2 RBD vaccines against SARS-related coronaviruses.

Issue Release: 2024

Exploring computational approaches to design mRNA Vaccine against vaccinia and Mpox viruses.

Issue Release: 2024

Opportunities and challenges to implementing mRNA-based vaccines and medicines: lessons from COVID-19.

Issue Release: 2024

A Comprehensive Review on the Intricate Interplay between COVID-19 Immunization and the New Onset of Pemphigus Foliaceus.

Issue Release: 2024

Personalized mRNA vaccine combined with PD-1 inhibitor therapy in a patient with advanced esophageal squamous cell carcinoma.

Issue Release: 2024

Macular perfusion changes in people administered two types of COVID-19 vaccines: optical coherence tomography angiography study.

Issue Release: 2024

Profiling antibody epitopes induced by mRNA-1273 vaccination and boosters.

Issue Release: 2024

Efficient and transfection of self-amplifying mRNA with linear poly(propylenimine) and poly(ethylenimine-propylenimine) random copolymers as non-viral carriers.

Issue Release: 2024

Developing variant-adapted COVID-19 vaccines to improve protection against Omicron and other recent variants: a plain language summary.

Issue Release: 2024

All-Trans-Retinoic Acid-Adjuvanted mRNA Vaccine Induces Mucosal Anti-Tumor Immune Responses for Treating Colorectal Cancer.

Issue Release: 2024

SARS-CoV-2 infection triggers more potent antibody-dependent cellular cytotoxicity (ADCC) responses than mRNA-, vector-, and inactivated virus-based COVID-19 vaccines.

Issue Release: 2024

Macular perfusion changes in people administered two types of COVID-19 vaccines: optical coherence tomography angiography study.

Issue Release: 2024

A careful look at lipid nanoparticle characterization: analysis of benchmark formulations for encapsulation of RNA cargo size gradient.

Issue Release: 2024

Waning immunity and IgG4 responses following bivalent mRNA boosting.

Issue Release: 2024

What Vaccines are Included in the Schedule?

How Does Environmental Hygiene Impact Vaccination?

What Systems are Used for Vaccine Reporting?

Why are Vaccines Important for Children?

Why is the MMR Vaccine Important?

How does EPI improve vaccine coverage?

What Are the Challenges in Developing These Vaccines?

What is the Ideal Timing for Childhood Vaccines?

How can the public trust the FDA's vaccine approval process?

How Effective Are Current Vaccines Against Omicron?

Partnered Content Networks

Relevant Topics